Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Morris

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Circulation. Cardiovascular Genetics|October 20, 2011
A gene expression signature that classifies human atherosclerotic plaque by relative inflammation statusOscar Puig, Jeffrey Yuan, Sergey Stepaniants, et al.
Chemical Biology & Drug Design|October 22, 2009
The design, synthesis and potential utility of fluorescence probes that target DFG-out conformation of p38alpha for high throughput screening binding assayHaile Tecle, Frederic Feru, Hu Liu, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of Thienoimidazole-Based HCV NS5A Genotype 1a and 1b InhibitorsSimon Giroux, Jinwang Xu, T Jagadeeswar Reddy, et al.
Clinical Chemistry|September 15, 2011
High-throughput simultaneous analysis of RNA, protein, and lipid biomarkers in heterogeneous tissue samplesVladimír Reiser, Ryan C Smith, Jiyan Xue, et al.
Bioorganic & Medicinal Chemistry Letters|January 18, 2015
Discovery of thienoimidazole-based HCV NS5A inhibitors. Part 1: C2-symmetric inhibitors with diyne and biphenyl linkersSimon Giroux, Darius Bilimoria, Caroline Cadilhac, et al.
Bioorganic & Medicinal Chemistry Letters|January 19, 2015
Discovery of thienoimidazole-based HCV NS5A inhibitors. Part 2: non-symmetric inhibitors with potent activity against genotype 1a and 1bSimon Giroux, Darius Bilimoria, Caroline Cadilhac, et al.
Bioorganic & Medicinal Chemistry Letters|June 15, 2007
N-(6,7-dichloro-2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-N-alkylsulfonamides as peripherally restricted N-methyl-D-aspartate receptor antagonists for the treatment of painChristopher Deur, Arun K Agrawal, Heidi Baum, et al.
Bioorganic & Medicinal Chemistry Letters|January 12, 2015
Synthesis and evaluation of NS5A inhibitors containing diverse heteroaromatic coresJames A Henderson, Darius Bilimoria, Monica Bubenik, et al.
Bioorganic & Medicinal Chemistry Letters|January 12, 2015
Benzimidazole-containing HCV NS5A inhibitors: effect of 4-substituted pyrrolidines in balancing genotype 1a and 1b potencyJames A Henderson, Darius Bilimoria, Monica Bubenik, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2009
Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritisMark E Schnute, Patrick M O'Brien, Joe Nahra, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Circulation. Cardiovascular Genetics|October 20, 2011
A gene expression signature that classifies human atherosclerotic plaque by relative inflammation statusOscar Puig, Jeffrey Yuan, Sergey Stepaniants, et al.
Chemical Biology & Drug Design|October 22, 2009
The design, synthesis and potential utility of fluorescence probes that target DFG-out conformation of p38alpha for high throughput screening binding assayHaile Tecle, Frederic Feru, Hu Liu, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of Thienoimidazole-Based HCV NS5A Genotype 1a and 1b InhibitorsSimon Giroux, Jinwang Xu, T Jagadeeswar Reddy, et al.
Clinical Chemistry|September 15, 2011
High-throughput simultaneous analysis of RNA, protein, and lipid biomarkers in heterogeneous tissue samplesVladimír Reiser, Ryan C Smith, Jiyan Xue, et al.
Bioorganic & Medicinal Chemistry Letters|January 18, 2015
Discovery of thienoimidazole-based HCV NS5A inhibitors. Part 1: C2-symmetric inhibitors with diyne and biphenyl linkersSimon Giroux, Darius Bilimoria, Caroline Cadilhac, et al.
Bioorganic & Medicinal Chemistry Letters|January 19, 2015
Discovery of thienoimidazole-based HCV NS5A inhibitors. Part 2: non-symmetric inhibitors with potent activity against genotype 1a and 1bSimon Giroux, Darius Bilimoria, Caroline Cadilhac, et al.
Bioorganic & Medicinal Chemistry Letters|June 15, 2007
N-(6,7-dichloro-2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-N-alkylsulfonamides as peripherally restricted N-methyl-D-aspartate receptor antagonists for the treatment of painChristopher Deur, Arun K Agrawal, Heidi Baum, et al.
Bioorganic & Medicinal Chemistry Letters|January 12, 2015
Synthesis and evaluation of NS5A inhibitors containing diverse heteroaromatic coresJames A Henderson, Darius Bilimoria, Monica Bubenik, et al.
Bioorganic & Medicinal Chemistry Letters|January 12, 2015
Benzimidazole-containing HCV NS5A inhibitors: effect of 4-substituted pyrrolidines in balancing genotype 1a and 1b potencyJames A Henderson, Darius Bilimoria, Monica Bubenik, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2009
Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritisMark E Schnute, Patrick M O'Brien, Joe Nahra, et al.
Pageof 7